Louisiana-Pacific (LPX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Research analysts at Seaport Res Ptn lifted their FY2024 earnings per share (EPS) estimates for Louisiana-Pacific in a research note issued on Monday, January 27th. Seaport Res Ptn analyst M.

Louisiana-Pacific (LPX) ended the recent trading session at $114.96, demonstrating a -0.09% swing from the preceding day's closing price. This move was narrower than the S&P 500's daily loss of 1.46%.

Short LPX slightly under 124.29, target 115.61, stop loss @ 124.65 Check the time stamp on this data. Updated AI-Generated ...

LPX-TI641 is a novel, orally bioavailable, potent small-molecule immunomodulator that restores immune tolerance by targeting multiple pathways implicated in autoimmune diseases.Topline Phase 1 ...

Louisiana-Pacific (LPX) ended the recent trading session at $103.87, demonstrating a +0.31% swing from the preceding day's closing price. This change outpaced the S&P 500's 0.22% loss on the day.

Louisiana-Pacific (LPX) closed the latest trading day at $103.14, indicating a -0.87% change from the previous session's end. The stock's change was less than the S&P 500's daily loss of 0.09%.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Louisiana-Pacific (LPX) closed the most recent trading day at $114.91, moving -0.55% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 1% for the day.